Evidence map›Paper›PMID 26303897›Full record

ArticleVirus genes2015

Megaprimer-mediated capsid swapping for the construction of custom-engineered chimeric foot-and-mouth disease virus.

Jitendra K Biswal, Saravanan Subramaniam, Gaurav K Sharma, Sonalika Mahajan, Rajeev Ranjan, Jyoti Misri, Bramhadev Pattnaik

Abstract read
PubMed Publisher
In one paragraph

Article in Virus genes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jitendra K BiswalICAR-Project Directorate on Foot-and-mouth Disease, Mukteswar, Nainital, 263138, Uttarakhand, India. jkubiswal@gmail.com.
Saravanan SubramaniamICAR-Project Directorate on Foot-and-mouth Disease, Mukteswar, Nainital, 263138, Uttarakhand, India.
Gaurav K SharmaICAR-Project Directorate on Foot-and-mouth Disease, Mukteswar, Nainital, 263138, Uttarakhand, India.
Sonalika MahajanICAR-Project Directorate on Foot-and-mouth Disease, Mukteswar, Nainital, 263138, Uttarakhand, India.
Rajeev RanjanICAR-Project Directorate on Foot-and-mouth Disease, Mukteswar, Nainital, 263138, Uttarakhand, India.
Jyoti MisriIndian Council of Agricultural Research, Krishi Bhavan, New Delhi, 110 001, India.
Bramhadev PattnaikICAR-Project Directorate on Foot-and-mouth Disease, Mukteswar, Nainital, 263138, Uttarakhand, India. pattnaikb@gmail.com.
Project Directorate on Foot and Mouth Disease · INIndian Council of Agricultural Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Foot-and-mouth disease (FMD) is a highly contagious, economically important disease of transboundary importance. Regular vaccination with chemically inactivated FMD vaccine is the major means of controlling the disease in endemic countries like India. However, the selection of appropriate candidate vaccine strain and its adaptation in cell culture to yield high titer of virus is a cumbersome process. An attractive approach to circumvent this tedious process is to replace the capsid coding sequence of an infectious full-genome length cDNA clone of a good vaccine strain with those of appropriate field strain, to produce custom-made chimeric FMD virus (FMDV). Nevertheless, the construction of chimeric virus can be difficult if the necessary endonuclease restriction sites are unavailable or unsuitable for swapping of the capsid sequence. Here we described an efficient method based on megaprimer-mediated capsid swapping for the construction of chimeric FMDV cDNA clones. Using FMDV vaccine strain A IND 40/2000 infectious clone (pA(40/2000)) as a donor plasmid, we exchanged the capsid sequence of pA(40/2000) with that of the viruses belonging to serotypes O (n = 5), A (n = 2), and Asia 1 (n = 2), and subsequently generated infectious FMDV from their respective chimeric cDNA clones. The chimeric viruses exhibited comparable infection kinetics, plaque phenotypes, antigenic profiles, and virion stability to the parental viruses. The results from this study suggest that megaprimer-based reverse genetics technology is useful for engineering chimeric vaccine strains for use in the control and prevention of FMD in endemic countries.

Indexed as

Recombination, GeneticCapsid ProteinsDNA PrimersFoot-and-Mouth Disease VirusMicrobial ViabilityMolecular BiologyPlasmidsVirologyCapsid ProteinsDNA PrimersCapsid SwappingChimeric FMDVFMD virusMegaprimer-PCR

Identifiers

PMID26303897
OpenAlexW1176787079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.